Skip to main content
NCBI home page
Occupational and Environmental Medicine logoLink to Occupational and Environmental Medicine
. 2003 Oct;60(10):746–751. doi: 10.1136/oem.60.10.746

Biological monitoring of occupational exposure to N,N-dimethylacetamide with identification of a new metabolite

L Perbellini 1, A Princivalle 1, M Caivano 1, R Montagnani 1
PMCID: PMC1740402  PMID: 14504362

Abstract

Aims: To study the concentration of N,N-dimethylacetamide (DMA) and its metabolite, N-methylacetamide (NMA), in urine of workers occupationally exposed to DMA in a factory producing synthetic acrylic fibres.

Methods: During the first phase, 223 workers exposed to low environmental concentrations of DMA provided urine samples at the end of a work shift. High concentrations of the unmodified solvent and its metabolite were found in a group of workers whose job was to start up machinery. The second and third phases focused on conditions favouring high uptake of DMA.

Results: The highest concentrations of unmodified solvent and NMA were found in the urine of workers recently engaged in starting up machinery. NMA in urine was 1.5–173.6 mg/g creatinine (median 20.5). In spite of the low environmental concentration, about 20% of the urine concentration of NMA was higher than 30 mg/g creatinine. Dermal absorption of DMA was high. A shower and a change of clothing at the end of the work shift, and washing away any solvent left on the skin, ensured that dermal absorption of DMA did not continue. This significantly reduced the NMA urinary concentration at values lower than 30 mg/g creatinine. In some urine samples, S-acetamidomethyl-mercapturic acid was identified by NMR analysis; this is probably a metabolite of N,N-dimethylacetamide—it has never before been identified in humans or animals.

Conclusions: Even at low environmental concentrations of DMA, dermal absorption can be considerable. Unmodified DMA and NMA concentrations in urine are good biomarkers for monitoring occupational exposure to the solvent.

Full Text

The Full Text of this article is available as a PDF (306.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnes J. R., Ranta K. E. The metabolism of dimethylformamide and dimethylacetamide. Toxicol Appl Pharmacol. 1972 Oct;23(2):271–276. doi: 10.1016/0041-008x(72)90190-1. [DOI] [PubMed] [Google Scholar]
  2. Borm P. J., de Jong L., Vliegen A. Environmental and biological monitoring of workers occupationally exposed to dimethylacetamide. J Occup Med. 1987 Nov;29(11):898–903. [PubMed] [Google Scholar]
  3. Corsi G. C. Sulla patologia professionale da dimetilacetamide (con particolare riferimento alla funzionalità epatica. Med Lav. 1971 Jan;62(1):28–42. [PubMed] [Google Scholar]
  4. Ghittori S., Imbriani M., Pezzagno G., Capodaglio E. The urinary concentration of solvents as a biological indicator of exposure: proposal for the biological equivalent exposure limit for nine solvents. Am Ind Hyg Assoc J. 1987 Sep;48(9):786–790. [PubMed] [Google Scholar]
  5. Kawai T., Yasugi T., Mizunuma K., Watanabe T., Cai S. X., Huang M. Y., Xi L. Q., Qu J. B., Yao B. Z., Ikeda M. Occupational dimethylformamide exposure. 2. Monomethylformamide excretion in urine after occupational dimethylformamide exposure. Int Arch Occup Environ Health. 1992;63(7):455–460. doi: 10.1007/BF00572111. [DOI] [PubMed] [Google Scholar]
  6. Kennedy G. L., Jr Biological effects of acetamide, formamide, and their monomethyl and dimethyl derivatives. Crit Rev Toxicol. 1986;17(2):129–182. doi: 10.3109/10408448609023768. [DOI] [PubMed] [Google Scholar]
  7. Kennedy G. L., Jr, Pruett J. W. Biologic monitoring for dimethylacetamide: measurement for 4 consecutive weeks in a workplace. J Occup Med. 1989 Jan;31(1):47–50. [PubMed] [Google Scholar]
  8. Kim S. N. Preclinical toxicology and pharmacology of dimethylacetamide, with clinical notes. Drug Metab Rev. 1988;19(3-4):345–368. doi: 10.3109/03602538808994140. [DOI] [PubMed] [Google Scholar]
  9. Malley L. A., Slone T. W., Jr, Makovec G. T., Elliott G. S., Kennedy G. L., Jr Chronic toxicity/oncogenicity of dimethylacetamide in rats and mice following inhalation exposure. Fundam Appl Toxicol. 1995 Nov;28(1):80–93. doi: 10.1006/faat.1995.1149. [DOI] [PubMed] [Google Scholar]
  10. Maxfield M. E., Barnes J. R., Azar A., Trochimowicz H. T. Urinary excretion of metabolite following experimental human exposures to DMF or to DMAC. J Occup Med. 1975 Aug;17(8):506–511. [PubMed] [Google Scholar]
  11. Nomiyama T., Omae K., Ishizuka C., Yamauchi T., Kawasumi Y., Yamada K., Endoh H., Sakurai H. Dermal absorption of N,N-dimethylacetamide in human volunteers. Int Arch Occup Environ Health. 2000 Mar;73(2):121–126. doi: 10.1007/s004200050017. [DOI] [PubMed] [Google Scholar]
  12. Spies G. J., Rhyne R. H., Jr, Evans R. A., Wetzel K. E., Ragland D. T., Turney H. G., Leet T. L., Oglesby J. L. Monitoring acrylic fiber workers for liver toxicity and exposure to dimethylacetamide. 1. Assessing exposure to dimethylacetamide by air and biological monitoring. J Occup Environ Med. 1995 Sep;37(9):1093–1101. doi: 10.1097/00043764-199509000-00010. [DOI] [PubMed] [Google Scholar]
  13. Stula E. F., Krauss W. C. Embryotoxicity in rats and rabbits from cutaneous application of amide-type solvents and substituted ureas. Toxicol Appl Pharmacol. 1977 Jul;41(1):35–55. doi: 10.1016/0041-008x(77)90052-7. [DOI] [PubMed] [Google Scholar]

Articles from Occupational and Environmental Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES